Related Experiment Video
Updated: Jun 18, 2026
06:30
Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats
Published on: May 23, 2025
Triamcinolone acetonide injection for persistent atypical idiopathic orbital inflammation
Alon Skaat1, Nachum Rosen, Mordechai Rosner
1Goldschleger Eye Institute, Sheba Medical Center, Tel Hashomer, Israel.
Orbit (Amsterdam, Netherlands)
|November 26, 2009
Summary
Intra-orbital injections of triamcinolone acetonide effectively treated atypical idiopathic orbital inflammation in a patient unresponsive to oral steroids. This targeted approach offers a promising alternative for managing refractory orbital inflammatory conditions.
Area of Science:
- Ophthalmology
- Inflammatory Diseases
Background:
- Idiopathic orbital inflammation (IOI) can present with varied clinical and histopathological features.
- Atypical presentations of IOI may pose diagnostic and therapeutic challenges.
Observation:
- A 71-year-old female presented with a right orbital mass and conjunctival inflammation, diagnosed as atypical IOI.
- Despite initial treatment with oral steroids, the patient's inflammation progressed.
- Repeated orbital biopsies confirmed the diagnosis of atypical IOI.
Findings:
- Intra-orbital injections of triamcinolone acetonide were administered.
- Significant improvement and cessation of active inflammation were observed following the injections.
Implications:
- Intra-orbital triamcinolone acetonide injections represent a viable therapeutic option for atypical IOI.
- This localized treatment may be particularly beneficial for patients refractory to systemic corticosteroid therapy.
Related Concept Videos
01:23Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
01:22Drug Delivery: Miscellaneous Routes
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...